India's Pharmaceutical Exports

Country Profile

Australia

Australia is a major destination for Indian pharmaceutical exports — $529M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $80K. The compound annual growth rate since FY2015 stands at 9.4%.

🇦🇺 #13 Destination · $529M · 2.7× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$529M
Exports FY2025–26 DGCIS
2.7×
Growth FY2015→2026
1.7%
Share of India Total
#13
Rank Among 178 Markets
9.4%
CAGR FY2015→2026
Australia is a major destination for Indian pharmaceutical exports — $529M in FY 2025–26, with 2.7× growth over the past decade. Medicines accounts for 90% of shipments, with vaccines contributing $80K. The compound annual growth rate since FY2015 stands at 9.4%.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $478M (90.5%) Surgical & Hospital Supplies $17.4M (3.3%) Medicine Ingredients $16.7M (3.1%) Traditional & Herbal $16.2M (3.1%) Vaccines $80K (0.0%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Australia in the RBI overseas direct investment dataset (2011–2026).